CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 02, 2022	Apr. 03, 2021
Cash Flows From Operating Activities:
Net income	$ 25,334	$ 5,798
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	5,819	4,848
Amortization of deferred debt issuance costs	1,740	2,140
Amortization and impairment of operating lease right of use assets	4,193	3,550
Non-cash share-based compensation	4,815	712
Loss on disposal of licenses, property and equipment	(112)	(4)
Fair value adjustments on interest rate derivatives	(38,256)	(2,820)
Gain on sale of businesses	(170)
Deferred income taxes	1,414	694
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable	(22,552)	(22,852)
Prepaid expenses	(1,253)	(1,684)
Other current and long-term assets	3,554	1,957
Accounts payable and other accrued liabilities	5,199	(15,763)
Accrued payroll and employee benefits	(1,546)	(7,595)
Insurance reserves	3,836	3,466
Operating lease liabilities	(4,370)	(4,126)
Other current and long-term liabilities	2,879	(1,232)
Net cash provided by operating activities	(9,476)	(32,911)
Cash Flows From Investing Activities:
Acquisitions of businesses, net of cash acquired	(1,394)	(500)
Proceeds from sale of businesses	460
Payment for interest rate cap	(11,725)
Purchases of property and equipment	(3,984)	(2,665)
Net cash used in investing activities	(16,643)	(3,165)
Cash Flows From Financing Activities:
Proceeds from securitization obligation	30,000
Repayment of securitization obligation	(10,000)
Principal payments on term loans	(2,150)
Principal payments on notes payable	(2,551)	(3,535)
Repayment of government stimulus funds		(29,444)
Principal payments of financing lease obligations	(181)	(203)
Payment of offering costs		(786)
Payment of debt issuance costs		(196)
Settlements with derivative counterparties	(2,050)
Net cash provided by (used in) financing activities	13,068	(34,164)
Net decrease in cash and cash equivalents	(13,051)	(70,240)
Cash and cash equivalents at beginning of period	30,490	137,345
Cash and cash equivalents at end of period	17,439	67,105
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	16,136	20,207
Acquisition of property and equipment on accrual	1,110	2,520
Offering costs included in accounts payable and other accrued liabilities		1,874
Cash paid for income taxes, net of refunds received	$ (161)	$ (202)